Strong Double-Digit Growth for Ceva in First Semester 2015

FRANCE - Consolidated sales of the Ceva Group reached €424 million at the end of June 2015, representing growth of 16 per cent and +12 per cent at constant perimeter and exchange rates.
calendar icon 23 July 2015
clock icon 2 minute read

Sales grew in all zones, except Europe which was stable versus last year, with strong performance in North America/Pacific region (+43 per cent), Asia (+38 per cent) and Latin America (+26 per cent).

All species are growing, especially Poultry (+27 per cent globally and +35 per cent on vaccines) and Companion Animals (+13 per cent).

The group delivered an operational result slightly ahead of the budgeted objective and continued to make significant investment in R&D (c.9 per cent of sales).

Marc Prikazsky, Ceva’s Chairman and CEO commented: “The growth of the group remains consistent and ahead of our 2020 business plan. It’s very pleasing to see that our previous investment to develop innovative new technology vaccines is being rewarded with increased business from our poultry customers. We have a significant new pipeline of products to launch, which will further boost our business in companion animals, swine and dairy.”

© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.